We at UTR Therapeutics Inc., are laser focused on bringing this first-in-class therapy to patients who need it most. We're proud of our rich pre-clinical pipeline which aims to tackle the biggest challenges and unmet need in #cancer and beyond. We welcome you to read about our latest work on our novel c-MYC drug, UTRxM1-18. Thank you to our partners, advisors, and mentors who continue to help us accelerate. Chidiebere Uzodinma Awah, Hiroshi Matsui, Kevin Struhl, Olorunseun Ogunwobi, Matt Mezer, Deerfield Management, Cure., LifeSci NYC Internship Program, New York City Economic Development Corporation, Nucleate, Nucleate New York. https://lnkd.in/e4g62Fm8
UTR Therapeutics Inc.
Biotechnology Research
New York, New York 94 followers
Changing the way we treat disease
About us
We are UTR Therapeutics Inc. a pre-clinical NYC based biotech born from the Nucleate Activator Program. Our technology is a breakthrough discovery which can overwrite any endogenous transcript. The technology can uniquely target and degrade any transcript of interest which we have proven in multiple difficult to treat cancers. Learn more by visiting us at www.utrtherapeutics.com or contacting us at [email protected] Notable Recognitions 2022: Nucleate Genentech Award Illumina Accelerator Sequencing Grant 2023: Deerfield Management and Economic Development Committee of NY xSeed Award 40 under 40 in Cancer [Chidiebere Awah], Association of Value Based Cancer Care (AVBCC) July 31 2023- Pre-IND Feedback from FDA for UTRxM1-18
- Website
-
www.utrtherapeutics.com
External link for UTR Therapeutics Inc.
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Cancer, mRNA Engineering, Biotech, Healthcare Innovation, Oncology, Therapeutics, Gene Therapy, Rare Disease, Cancer Research, RNA Therapeutics, Nanotechnology, Cell & Gene Therapy, and Biopharma Delivery System
Locations
-
Primary
Get directions
New York, New York 10016, US
Employees at UTR Therapeutics Inc.
Updates
-
Tune in to learn more about this first-in-class therapeutic approach. #drugdevelopment #drugdiscovery #cancer #mRNA
Genome Engineer Fellow , City University of New York Principal Investigator, UTR Therapeutics Inc.
Cure will re-broadcast this interview, the Tuesday talks on Tuesday 16th July, 2024 at 12:30 PM ET. It will air it across Twitter @cure345, on LinkedIn and our new website at www.wewillcure.com Cure. UTR Therapeutics Seema Kumar# Novel mRNA drugs, # breakthrough medicine for deadly diseases.
-